Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04168372 · ClinicalTrials.gov registry record · NA
Fructose: Substrate, Stimulus, or Both?
A NA study, sponsored by Touro University, California.
- Active
- Registry status
- NA
- Development phase
- 35
- Enrollment target
NCT04168372: Active NA study, sponsored by Touro University, California.
NCT04168372 is a NA study that is active but no longer recruiting, run by Touro University, California. The registered enrollment target is 35 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04168372, a NA study, is active but no longer recruiting, sponsored by Touro University, California.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 35 participants
- Enrollment target
Study Summary
This objective of this study is to use sensitive methodology under controlled conditions to investigate the mechanisms by which fructose consumption contributes to excess fatty acid synthesis and elevations in blood glucose levels following consumption of meals containing fructose.
Primary Outcome
Measured by the detection of 13C carbons in TRL-palmitate from administered 13C labeled pyruvate or 13C labeled fructose.
Interventions
- OTHER High fructose, fructose labeled meal
- OTHER High fructose, pyruvate labeled meal
- OTHER Low fructose, fructose labeled meal
- OTHER Low fructose, pyruvate labeled meal
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 35 participants |
| Start Date | 2019-09-15 |
| Est. Completion | 2027-07-20 |
| Phase | NA |
What the registry record for NCT04168372 still lists
NCT04168372 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 35 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).
The record links to 0 conditions, and to 4 interventions - of which High fructose, fructose labeled meal is the first listed.
NCT04168372 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04168372 about?
NCT04168372 is a clinical study titled "Fructose: Substrate, Stimulus, or Both?". This objective of this study is to use sensitive methodology under controlled conditions to investigate the mechanisms by which fructose consumption contributes to excess fatty acid synthesis and elevations in blood glucose levels following consumption of meals containing fructose.
What is the current status of trial NCT04168372?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 35 participants. The study started on 2019-09-15. Estimated completion is 2027-07-20.
What interventions are being tested in trial NCT04168372?
The interventions under investigation include: High fructose, fructose labeled meal (OTHER), High fructose, pyruvate labeled meal (OTHER), Low fructose, fructose labeled meal (OTHER), Low fructose, pyruvate labeled meal (OTHER).
Who is sponsoring clinical trial NCT04168372?
This trial is sponsored by Touro University, California, which has 5 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04168372's enrollment target sits among peer trials
35 1564th of 2000 higher than 431 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01697371 · 35 participants · NA
Proton Therapy in the Treatment of Liver Metastases
- NCT01940757 · 35 participants · Phase 1
Experimental Infection of Hookworm-naïve Adults With Dermally-applied Infectious Necator Americanus Hookworm Larvae
- NCT02235857 · 35 participants · NA
Post Approval Study of Liposorber LA-15 System for the Treatment of Focal Segmental Glomerulosclerosis in Children
- NCT02637934 · 35 participants · Phase 1
Phase I Pilot Study of Biodistribution, Metabolism and Excretion of Novel Radiotracer [18F]Fluorthanatrace (FTT) by PET/CT
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI